Wellington Management Group
TEVA icon

Wellington Management Group’s Teva Pharmaceuticals TEVA Stock Holding History

Wellington Management Group’s Portfolio TEVA Stock Details TEVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q1 		– Sell
-3,629
Closed -$1.31M – 2316
2017
Q4 		$1.31M Sell
3,629
-396
-10% -$5.96K ﹤0.01% 1837
2017
Q3 		$865K Buy
4,025
+3,025
+303% +$68.1K ﹤0.01% 1923
2017
Q2 		$620K Buy
+1,000
New +$31K ﹤0.01% 1990

Other funds holding TEVA

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
HIIFS
Harel Insurance Investments & Financial Services Ramat Gan, Israel $14.7B AUM 47% 1-Year Est. Return
PF
Phoenix Financial Givatayim, Israel $10.5B AUM 49.21% 1-Year Est. Return
MMH
Menora Mivtachim Holdings Ramat Gan, Israel $21.1B AUM 40.03% 1-Year Est. Return
WCM Investment Management
WCM Investment Management Laguna Beach, California $43.8B AUM 42.28% 1-Year Est. Return
CI
Clal Insurance Tel-Aviv, Israel $16.6B AUM 68.34% 1-Year Est. Return
MIFH
Migdal Insurance & Financial Holdings Petach Tikva, Israel $11.5B AUM 52.5% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
LIM
Lingotto Investment Management London, United Kingdom $5.06B AUM 91.14% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Wellington Management Group's TEVA Position: Q1 2026 in Review

Wellington Management Group increased its Teva Pharmaceuticals (TEVA) stake by 6.9% in Q1 2026, buying an estimated $15M and bringing the position to 7,251,828 shares worth $218M. The position accounts for 0.04% of the portfolio, ranked #362.

Wellington Management Group first reported a position in TEVA in Q2 2013 and has held it in 52 quarters since. The position peaked at $2.4B in Q2 2013. 650 funds tracked by Wall St. Rank hold TEVA as of Q1 2026.

  • Wellington Management Group held 7,251,828 shares of Teva Pharmaceuticals worth $218M as of Q1 2026.
  • Wellington Management Group bought 466,099 Teva Pharmaceuticals shares in Q1 2026, an estimated $15M.
  • Teva Pharmaceuticals made up 0.04% of Wellington Management Group's portfolio in Q1 2026, its #362 holding.
  • Wellington Management Group first reported a position in Teva Pharmaceuticals in Q2 2013 and has held it in 52 quarters since.
  • Wellington Management Group's Teva Pharmaceuticals position peaked at $2.4B in Q2 2013.
  • 650 funds tracked by Wall St. Rank held Teva Pharmaceuticals as of Q1 2026.

Based on Wellington Management Group's 13F filing for Q1 2026, filed 15 May 2026.